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A B S T R A C T
Background
Autism spectrum disorders (ASDs) are characterised by impairments in communication and reciprocal social interaction. These im-
pairments can impact on relationships with family members, augment stress and frustration, and contribute to behaviours that can
be described as challenging. Family members of individuals with ASD can experience high rates of carer stress and burden, and poor
parental efficacy. While there is evidence to suggest that individuals with ASD and family members derive benefit from psychological
interventions designed to reduce stress and mental health morbidity, and enhance coping, most studies to date have targeted the needs
of either individuals with ASD, or family members. We wanted to examine whether family (systemic) therapy, aimed at enhancing
communication, relationships or coping, is effective for individuals with ASD and their wider family network.
Objectives
To evaluate the clinical effectiveness and acceptability of family therapy as a treatment to enhance communication or coping for
individuals with ASD and their family members. If possible, we will also seek to establish the economic costs associated with family
therapy for this clinical population.
Search methods
On 16 January 2017 we searched CENTRAL, MEDLINE, Embase, 10 other databases and three trials registers. We also handsearched
reference lists of existing systematic reviews and contacted study authors in the field.
Selection criteria
Randomised controlled trials (RCTs) and quasi-RCTs investigating the effectiveness of family therapy for young people or adults with
ASD or family members, or both, delivered via any modality and for an unspecified duration, compared with either standard care, a
wait-list control, or an active intervention such as an alternative type of psychological therapy.
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Data collection and analysis
Two authors independently screened each title and abstract and all full-text reports retrieved. To enhance rigour, 25% of these were
independently screened by a third author.
Main results
The search yielded 4809 records. Of these, we retrieved 37 full-text reports for further scrutiny, which we subsequently excluded as
they did not meet the review inclusion criteria, and identified one study awaiting classification.
Authors’ conclusions
Few studies have examined the effectiveness of family therapy for ASD, and none of these are RCTs. Further research studies employing
methodologically robust trial designs are needed to establish whether family therapy interventions are clinically beneficial for enhancing
communication, strengthening relationships, augmenting coping and reducing mental health morbidity for individuals with ASD and
family members.
P L A I N L A N G U A G E S U M M A R Y
Family therapy for autism spectrum disorders
Review question
What is the evidence that family therapy can help to improve communication, strengthen relationships, and enhance coping, mental
health and well-being for people who have autism spectrum disorders (ASDs) or their family members, or both?
Background
People with ASD often experience difficulty with knowing how to communicate with others, and with developing and maintaining
friendships and relationships. They can also find it difficult to manage changes to their routine. People with ASD tend to rely on
family members, including parents and siblings, well into adulthood. Family members of people with ASD sometimes experience stress,
anxiety and depression.
Several research studies have investigated the benefits of talking therapies for individuals with ASD or for family members. While study
findings suggest that these therapies can improve communication and coping, and mental health and well-being, outcomes are usually
reported for the person with ASD or family members, but not both.
Family therapy is designed to help people within the family make sense of difficult situations, and help them work together to develop
new ways of thinking about and managing these difficulties. It is important to find out if family therapy can be helpful for people with
ASD and their relatives given that the core symptoms of ASD, and additional difficulties people can experience, often impact on the
family unit.
We searched for all the available evidence, published or unpublished, up until 16 January 2017, which examined family therapy for
ASD.
Study characteristics
While there have been a few studies investigating the benefits of family therapy interventions for ASD, none have compared family
therapy with either no treatment, a group of people waiting to start treatment, or another type of psychological therapy. There is one
study awaiting classification.
Quality of the evidence
There is limited high-quality evidence available about whether family therapy is helpful for people with ASD or their family members.
More research studies are needed to evaluate the effectiveness of family-focused interventions to enhance communication, reduce stress
and improve coping.
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B A C K G R O U N D
Description of the condition
Autism spectrum disorders (ASDs) are a cluster of childhood-
onset, neurodevelopmental conditions characterised by qualitative
impairments in communication, reciprocal social interaction, and
restricted and repetitive interests and behaviours (WHO 1992).
There is substantial heterogeneity in the ASD symptomprofile and
clinical presentation; hence, diagnosis is often not made until late
adolescence or adulthood (NICE 2012). Once thought to be fairly
rare, current prevalence estimates indicate that ASD is relatively
common, affecting at least 1% of the population (Brugha 2011).
The degree of impairment resulting from core ASD characteris-
tics varies widely. Educational attainments are often poorer for
younger people with ASD in comparison to typically developing
peers (Levy 2011). Similarly, the adult ASD population experi-
ences significant difficulty with gaining and sustaining meaning-
ful employment (Howlin 2013; Mavranezouli 2014). A lack of
peer and intimate relationships are frequently the norm (White
2009a), leading to diminished social opportunities beyond those
that stem from the family network, social isolation and loneliness.
Daily living and self-sufficiency skills can also be impeded, and in-
dividuals with ASDoften depend on ongoing support from family
members well into adulthood (Gray 2014; Magiati 2014).
ASDs are commonly associated with learning disability and high
rates of psychiatric comorbidity (Hofvander 2009; Joshi 2013;
Simonoff 2008), including anxiety disorders (Van Steensel 2011;
White 2009b), depression (Ghaziuddin 2002), attention deficit
hyperactivity disorder traits (Taylor 2013), and more general
“emotional and behavioural problems” (Maskey 2013). Comor-
bidities further compound difficulties across multiple domains of
functioning and exacerbate reliance on family members as well as
carer stress and burden (Cadman 2012).
The experiences and needs of family members of individuals with
ASD have garnered increasing attention in recent years. Findings
from epidemiological and genetic studies indicate that ASD is a
highly heritable condition (Hallmayer 2011; Lichtenstein 2010;
Lundström 2010). Also, studies have found that parents of people
with ASD can present with higher levels of stress, distress, fatigue,
anxiety, and depression symptoms than those reported for par-
ents of typically developing or other clinical populations (Cadman
2012; Firth 2013; Giallo 2013; Hoefman 2014). Additionally, re-
search findings suggest that carers can experience concerns about
their parental efficacy and coping (Karst 2012), and that marital
satisfaction can be affected (Hartley 2011). There has been some,
albeit limited, research about siblings of individuals with ASD.
Tentative study findings suggest that some siblings may experi-
ence slightly elevated levels of “behavioural problems” compared
to non-clinical populations (Hastings 2014), or features of anxi-
ety (Shivers 2013). Sibling adjustment and relationships may be
affected by the severity of ASD and associated symptoms (Petalas
2012; Rivers 2003). Siblings may also be expected to take on more
household duties (e.g. chores), or more responsibility (e.g. infor-
mal caregiving) compared to the individual with ASD, although
this is not a consistent finding across studies (Meirsschaut 2011).
Description of the intervention
Family therapy can be defined as a formal, psychotherapeutic in-
tervention, which seeks to understand and enhance relationships,
communication, and functioning between members of a family
(Dallos 2010). While there are several types of family therapy,
they are predominantly underpinned by systemic theories and
share central tenets (Hayes 1991). First, it is proposed that various
problems, such as mental health functioning or the development
and maintenance of interpersonal relationships, are contextually
bound (that is, they are likely to be predisposed and perpetu-
ated by the context and system(s) within which they occur, rather
than solely being attributed to the individual themselves) (Dallos
2010). Second, it is suggested that societal and cultural norms,
values and expectations influence and shape familial beliefs and
behaviours both collectively (that is, the intergenerational family
unit) and individually, and that problems are best understood and
addressed in terms of these influences. Third, it is hypothesised
that the family unit and the relationships between familymembers
are dynamic (that is, that the reactions and responses of one per-
son affect those of others in the system, in a bi-directional fashion,
linearly and longitudinally). Fourth, families are said to develop
ways of coping with periods of change and transition (e.g. births,
marriages and bereavements), and illness or adversity, in order to
maintain stability as a unit (Goldenberg 2012). Often these pat-
terns of coping are adaptive and shared between all family mem-
bers; yet, on occasion, individuals (within the family) may adopt
distinct coping styles leading to communication and relationship
difficulties. Finally, it is considered that there are commonalities
in the ways that family members use language and narratives to
converse and make sense of their own and others’ experiences but
also subtle differences, which, in turn, may lead to or exacerbate
ambiguity, misinterpretation or disagreements.
Family therapists use a range of interventions (Dallos 2010), in-
cluding psychoeducation; development of genograms to map out
cultural, resilience or other familial patterns (Butler 2008); nar-
rative techniques (e.g. to explore language, meanings and attribu-
tions) (Carr 1998); and the use of particular questioning styles
(e.g. circular and reflexive questions to enhance the breadth and
depth of discussion) (Hayes 1991). In clinical practice, individu-
als presenting for family therapy may be part of the same family
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or part of the wider friendship group. Individuals are encouraged
to decide for themselves who can and will engage in treatment,
and the configuration of those attending may vary from session
to session. The duration of therapy can be several weeks to several
months. Choices about the number of sessions to offer are largely
dependent on the service model and constraints, familial present-
ing needs and the therapist’s theoretical stance.
How the intervention might work
Family therapy for ASD can be hypothesised to work in sev-
eral ways (Goepfert 2015; Helps 2016; Ramisch 2013; Solomon
2012). Individuals with ASD and family members can be sup-
ported to understand andmake sense of the diagnosis (e.g. through
the use of psychoeducation). Discussion can be facilitated about
preferences for using different terminology to describe the core
symptoms (e.g. autism spectrum ‘disorder’ or autism spectrum
‘condition’) and the narratives and meanings that arise from this
for individuals and the family unit collectively. The impact of core
characteristics (e.g. engagement in routines or impairments in so-
cioemotional reciprocity such as a lack of empathy) can be ex-
ploredwith a view to reducing feelings of frustration or annoyance.
Interventions can encourage discussion about broad factors and
familial patterns or responses that may contribute to difficulties
with communication and relationships or challenging behaviour,
and support the identification of strategies to promote cohesion
within the system. Family therapy can also encourage open dia-
logue between carers (e.g. about potential guilt or feelings of stress
or worry), and, in turn, strategies can be developed to enhance
marital relationships, resilience and coping, and positive parental
mental health. Family therapy also provides a supportive thera-
peutic space for siblings to explore their concerns or unanswered
questions (e.g. about heredity factors or their current and potential
prospective role as a carer).
Why it is important to do this review
ASDs are common, lifelong disorders characterised by overt and
subtle qualitative impairments in communication, social interac-
tion and relatedness, and preferences for engaging in restricted in-
terests and repetitive behaviours (WHO 1992). Difficulties with
tolerating uncertainty, ambiguity, and change within and beyond
the immediate environment are additional hallmark characteris-
tics (APA 2013). Core ASD symptoms can impact significantly on
daily social and occupational functioning during childhood and
adulthood. Individuals with ASD may find it difficult to initiate
and sustain interactions with others despite the desire for relation-
ships (and increased social opportunities). Also, symptoms of ASD
typically impact others in the family (Hoefman 2014). Parents
(carers) and siblings often must accommodate restricted interests
and adherence to seemingly non-functional routines. Inherent dif-
ficulties with communication and interaction can adversely affect
relationships with, and between, family members. The need to
provide intensive and ongoing support to individuals with ASD
can incur stress, anxiety and depression in carers, as well as poor
perceived parental efficacy and coping (Karst 2012).
There is no cure for ASD per se, and the heterogeneity of the
disorder negates the use of monotherapy. Instead, the more par-
simonious approach is to develop combinations of interventions
that 1) reduce or ameliorate the effect and impact of core ASD
symptoms, and 2) support individuals and others around them to
enhance their repertoire of skills (Smith 2014; Woodman 2015).
Further, interventions are needed across the lifespan to address the
needs of children as well as adults with ASD. There is promis-
ing evidence for the use of psychological interventions for indi-
viduals with ASD, such as behavioural and cognitive-behavioural
(Lang 2010; Spain 2015a; Sukhodolsky 2013), social cognition
(Fletcher-Watson 2014), and skills-based interventions (Reichow
2013; Spain 2015b), but a limitation to these approaches is that
they do not explicitly address relationship and communication is-
sues between family members, nor do they seek to enhance famil-
ial coping strategies or resilience factors. Similarly, a recent review
has highlighted the potential effectiveness of parent training for
ASD (Oono 2013), but this approach encourages parents to take
on a more facilitative role, rather than specifically targeting their
(potential) concurrent needs and the bi-directional relationship
between individuals. Conversely, family therapy is amore inclusive
intervention and has been found to be effective for different clini-
cal populations (Carr 2009). Whether the structure or content of
family therapy for individuals with ASD requires adaptation (as is
the case for other psychological therapies), for example to accom-
modate the impact of inherent impairments, is not wholly clear.
Undertaking a systematic review of the empirical data is important
in order to:
1. ascertain the potential effectiveness and acceptability of
formal family therapy work for individuals with ASD;
2. establish whether there are integral features of these
approaches that are associated with improved outcomes; and
3. consider how best interventions can be tailored to the
specific lifelong needs of this clinical population and their family
members.
O B J E C T I V E S
To evaluate the clinical effectiveness and acceptability of family
therapy as a treatment to enhance communication or coping for
individuals with ASD and their family members. If possible, we
will also seek to establish the economic costs associated with family
therapy for this clinical population.
M E T H O D S
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Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and quasi-RCTs (in which
participants were allocated by alternate allocation, for example
according to days of the week). We excluded cross-over trials and
studies employing non-RCT designs (such as case studies or case
series), due to the methodological limitations these can incur.
Types of participants
Families that have at least one person - child or adolescent (aged
17 years and under) or adult (aged 18 years and over) - diagnosed
with an ASD.
We defined ASD according to clinical criteria of either the Interna-
tional Classification of Diseases (WHO1992), or theDiagnostic and
StatisticalManual ofMentalDisorders (APA 2013), and ideally (but
not necessarily) diagnosed using standardised methods of assess-
ment (e.g. the AutismDiagnostic Interview - Revised (Lord 1994),
or the Autism Diagnostic Observation Schedule (Lord 2000)).
We defined familymembers as individuals frommulti-generations
(parents, grandparents, siblings, children, or spouses), either bio-
logically related to the individual with ASD, or related through
marriage or cohabitation. We also included non-professional car-
ers (e.g. individuals providing foster or respite care) and significant
others such as friends.
We included studies that described interventions delivered to par-
ticipants residing in the same dwelling, or interventions offered to
family members living separately.
We included studies in which participants had a comorbidity or
were receiving other treatments concurrently to the family therapy,
although the intentionwas to clarify this level of detail from reports
or by contacting trial authors.
Types of interventions
Family therapy
We included family therapy interventions delivered by at least one
suitably qualified clinician, derived from systemic theories, and
specifically focusing on understanding, enhancing and improv-
ing aspects of relationships between individuals with ASD and at
least one family member; or between two or more members of
the family of an individual with ASD (e.g. parents, or parents and
siblings). We included the following modalities of family therapy:
systemic therapy; structural family therapy; strategic family ther-
apy; Milan approaches; solution-focused therapy; narrative ther-
apy; and behavioural family therapy. The intervention had to have
been offered either face-to-face or via web-based real-time sessions.
We excluded studies that described pure bibliotherapy, psychoe-
ducation or parent training techniques. There was no stipulation
regarding the number or duration of sessions delivered.
Control condition
We included four main types of comparator interventions.
1. No treatment.
2. Provision of standard clinical care (i.e. treatment as usual).
3. A wait-list control (e.g. a delayed-start intervention).
4. An active comparator (e.g. an alternative psychological
intervention such as applied behavioural analysis or cognitive
behavioural therapy).
Types of outcome measures
We identified primary and secondary outcomes for individuals
with ASD and family members. We included outcome measures
that generated either dichotomous or continuous data. To be eligi-
ble for inclusion, outcomemeasures needed to be standardised and
validated. While measures may not necessarily have been specifi-
cally validated for use with the ASDs population, many interven-
tion studies that include participants with ASD utilise measures
(e.g. self-report questionnaires) that have been validated in non-
ASD samples (Lang 2010; Reichow 2013; Spain 2015a; Spain
2015b). The intention was to describe the psychometric proper-
ties of outcome measures, when possible, and highlight whether
there are indicative, normative thresholds (that is, cut-off scores)
for ASD samples.
Outcomemeasures could have been completed by individualswith
ASD, family members, or via objective (clinician-administered)
instruments. Outcome measures could have been completed at
different time points, including postintervention or at follow-up,
or relating to short-term changes (such as attributions about cop-
ing or satisfaction with the intervention), and longer-term out-
comes (such as direct and indirect costs).
Primary outcomes
1. Quality or quantity of social interaction and
communication (e.g. Social Responsiveness Scale by Constantino
2003; Autism Diagnostic Observation Schedule by Lord 2000).
2. Mental health morbidity, including stress, anxiety or
depression (e.g. Hospital Anxiety and Depression Scale by
Zigmond 1983).
3. Quality of life (e.g. EQ-5D by Szenda 2007), including
quality of relationships with family members (e.g. Family
Questionnaire by Wiedemann 2002).
4. Adverse effects or events (e.g. increased mental health
morbidities, as measured by the Hospital Anxiety and Depression
Scale (Zigmond 1983); or an increase in challenging behaviour).
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Secondary outcomes
1. Confidence in, or attributions about, coping (e.g.
Attributional Style Questionnaire by Seligman 1984).
2. Satisfaction with treatment (e.g. Client Satisfaction
Questionnaire by Attkisson 1982).
3. Dropout from treatment.
4. Health economic outcomes, including direct costs (e.g.
treatment costs) and indirect costs (e.g. use of clinical services or
work absence due to stress).
Search methods for identification of studies
We used a search strategy that combined two concepts: the condi-
tion (ASD) AND intervention (family therapy). We did not limit
the search by language, date, or publication status.
Electronic searches
We searched the following electronic databases and trial registers
between 22 October and 4 November 2015 and again in January
2017:
1. Cochrane Central Register of Controlled Trials
(CENTRAL; 2016, Issue 11) in the Cochrane Library, which
includes the Cochrane Developmental, Psychosocial and
Learning Problems Specialised Register (searched 18 January
2017);
2. MEDLINE Ovid (1946 to December Week 1 2016);
3. MEDLINE Ovid Epub Ahead of Print (16 January 2017);
4. MEDLINE Ovid In-Process & Other Non-Indexed
Citations (16 January 2017);
5. Embase Ovid (1974 to 2017 Week 03);
6. CINAHL Plus EBSCOhost (Cumulative Index to Nursing
and Allied Health Literature; 1937 to 17 January 2017);
7. Cochrane Database of Systematic Reviews (CDSR; 2017, Issue
1) part of the Cochrane Library (searched 18 January 2017);
8. Database of Abstracts of Reviews of Effects (DARE; 2015,
Issue 2) part of the Cochrane Library (searched 18 January
2017);
9. ERIC EBSCOhost (Education Resources Information
Center; 1966 to 17 January 2017);
10. PsycINFO Ovid (1967 to January Week 2 2017);
11. Sociological Abstracts ProQuest (1952 to 18 January 2017);
12. Dissertation Abstracts International ProQuest (1743 to 16
January 2017);
13. AutismData (autism.org.uk/autismdata; searched 18
January 2017);
14. UK Clinical Trials Gateway (UKCTG; ukctg.nihr.ac.uk;
searched 18 January 2017); replaces UK Clinical Research
Network Study Portfolio.
15. ClinicalTrials.gov (clinicaltrials.gov; searched 18 January
2017);
16. World Health Organisation International Clinical Trials
Registry Platform (WHO ICTRP; apps.who.int/trialsearch/
default.asp; searched 18 January 2017).
The exact strategy for each database is reported in Appendix 1.
See Appendix 2 for a detailed summary of the searches to date.
Searching other resources
We also undertook additional searches as follows: 1) we hand-
searched the reference lists of 10 review papers (Banda 2015;
Cridland 2014; Dababnah 2016; Da Paz 2017; Gingerich 2013;
Goepfert 2015; Karst 2012; Kaslow 2012; Ramisch 2013; Wainer
2016); and 2) we contacted a number of clinicians, including re-
searchers who have undertaken studies in the field, to ask if they
knew of any studies not already identified by the searches.
Data collection and analysis
Selection of studies
Selection of studies involved several steps.We initially imported all
citations retrieved from the searches into EndNote (EndNote X7).
After removing duplicates, DS and JS independently screened the
list of titles and abstracts for relevance. Next, DS and JS inspected
full reports of studies that appeared relevant or for which more
information was needed. They then independently assessed each
text for eligibility based on the inclusion criteria outlined above
(Criteria for considering studies for this review). To enhance reli-
ability and rigour, EP independently reviewed a random 25% of
the total sample of all titles and abstracts obtained, and a random
25% of all full-text reports retrieved. There were no disputes about
the screening and inspection of reports.We recorded our decisions
in a study flow diagram (Moher 2009).
Data extraction and management
No studies met the inclusion criteria for this review (Criteria for
considering studies for this review).
Please see the protocol (Spain 2015c) and Table 1 for more in-
formation on methods archived for use in future updates of this
review.
R E S U L T S
Description of studies
Results of the search
Please see Figure 1 for a flow diagram of the selection process.
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Figure 1. Study flow diagram.
Our searches yielded 4805 database records (Electronic searches),
and four additional records from other sources (Searching other
resources). We removed 1536 duplicates and reviewed 3273
records for eligibility (Criteria for considering studies for this
review). Two review authors (DS, JS) independently screened all
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titles and abstracts. A third author (EP) screened 800 titles and
abstracts (25%) independently to enhance rigour. We excluded
3234 records, as none of these pertained to RCTs of family therapy
for people with ASD.
We retrieved a total of 37 full-text reports for further evaluation.
Thirty-four reports were written in English, one was written in
Chinese (Chen 2006), one in Japanese (Abe 2014), and one in
German (Goll-Kopka 2009). None of these described RCTs of
family therapy and all were excluded (see Excluded studies). One
excluded study, Wagner 2014, made reference to another, poten-
tially relevant study. We contacted the author on two occasions
but no further information was available at this time, therefore we
classified this as awaiting classification (Spain 2017 [pers comm]).
Included studies
None of the reports retrieved met the inclusion criteria for this
review (Criteria for considering studies for this review).
Excluded studies
We excluded 37 reports. We excluded 11 discussion papers or
reviews (Affleck 1982; Alonim 2004; Brockman 2016; Coleman
2015; Heller 2015; Helps 2016; Johnson 2012; Lordi 1964;
Pickard 2017; Smock Jordan 2016; Wagner 2014), one obser-
vational report (Altiere 2009), one qualitative study (Coogle
2016), and 24 intervention studies that were not RCTs of fam-
ily therapy (Abe 2014; Aerts 2011; Allen 1980; Alquraini 2015;
Bennett 1983; Bennett 1986; Casenhiser 2011; Chen 2006; Chou
1992; Clancy 1972; Davis 1991; George 1988; Drahota 2008;
Estreicher 1982; Goll-Kopka 2009; Keen 2010; NCT01919970;
Pillay 2010; Roux 2013; Shank 1991; Siller 2013; Solomon 2008;
Wang 2008; Whittingham 2009).
See Characteristics of excluded studies tables.
Risk of bias in included studies
Given that no studies met the review inclusion criteria (Criteria
for considering studies for this review), we were unable to assess
risk of bias.
Effects of interventions
It was not possible to establish intervention effectiveness, given
the absence of data.
D I S C U S S I O N
Summary of main results
We sought to establish the clinical and cost effectiveness of family
therapy for individuals with ASD. Despite an extensive search,
no RCTs met the a priori review inclusion criteria (Criteria for
considering studies for this review), implying a gap in the literature.
One study is awaiting classification as no further information is
available at this time.
Overall completeness and applicability of
evidence
We were unable to assess completeness and applicability of evi-
dence as no studies were included in this review.
Quality of the evidence
We were unable to assess the quality of the evidence as no studies
were included in this review.
Potential biases in the review process
We consider that our search was rigorous and comprehensive.
We conducted searches in 13 databases, including seeking unpub-
lished studies such as those described in dissertations and the grey
literature. We also handsearched the reference lists of a number of
systematic and literature reviews. Finally, we contacted a couple
of study authors to ascertain whether they were aware of trial data
that may be eligible for inclusion in this review.
Agreements and disagreements with other
studies or reviews
No other systematic reviews focusing on RCTs of family ther-
apy or systemic therapy for ASD were retrieved by our search.
We identified (but excluded) a few non-randomised intervention
studies that incorporated elements of systemic therapy for family
members of individuals with ASD (e.g. George 1988; Goll-Kopka
2009; Wagner 2014). Evidence from these studies suggests that
knowledge and understanding of the core disorder (i.e. ASD), and
coping styles may be improved postintervention, albeit that use of
less rigorous study designs means that results should be interpreted
with a degree of caution.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
In spite of uncertainty about effects, it may be that family therapy
is deemed clinically appropriate, either in conjunction with other
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prescribed treatments or as a stand-alone intervention. Decisions
to use family therapy should be made in consultation with suitably
qualified multidisciplinary professionals. Also, the use of family or
systemic therapies should be informed by best practice guidance
for clinical work with this population (NICE 2012).
Implications for research
There are several implications for research. Building on the liter-
ature to date, there is a need for further intervention studies that
employ methodologically rigorous trial designs (i.e. RCTs). This
may include studies that examine the clinical utility and effective-
ness of psychoeducation for family members, couples therapy to
strengthen relationships and coping when one parent has ASD,
and family or systemic therapy for parents, siblings, grandparents
and children of people with ASD, and dyads (e.g. members of
two generations and young people or adults with ASD and mem-
bers of the immediate and extended family). Whether particular
systemic approaches glean more favourable outcomes is yet to be
established, but this warrants further investigation. Similarly, con-
sideration of treatment mediators and moderators would prove
beneficial. As a secondary objective, intervention studies should
undertake process evaluations to establish satisfaction and accept-
ability of these interventions for family members.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abe 2014 This is a non-RCT study examining the effectiveness of a support group for family members of people with
developmental disabilities. This support group is not family therapy
Aerts 2011 This is a non-RCT study comprising a psychiatric family treatment for family members of individuals with
autism. The intervention was competency based and is not family therapy
Affleck 1982 This is a review paper synthesising information about parent training approaches for individuals with devel-
opmental disabilities
Allen 1980 This is a two-arm study comprising a transdisciplinary, early intervention programme for young children
with, or known to be at risk of, developmental disabilities compared to a treatment-as-usual group. Neither
intervention is family therapy
Alonim 2004 This is a discussion paper about an early-intervention approach for young people with ASD
Alquraini 2015 This is a non-RCT study comprising a relationship-focused intervention to alleviate stress in mothers of people
with ASD. The intervention is not family therapy per se
Altiere 2009 This is a cross-sectional study investigating family dynamics and coping in parents of individuals with ASD
Bennett 1983 This is a two-arm study comprising a family-oriented treatment for parents of children with disabilities
(primarily cerebral palsy) compared to a wait-list control. Neither arm is family therapy
Bennett 1986 This is a two-arm study comprising a family-oriented treatment for parents of children with disabilities
(primarily cerebral palsy) compared to a wait-list control. Neither arm is family therapy
Brockman 2016 This is a discussion paper, which provides an overview of the use of family therapy techniques for people with
ASD and family members. No RCT primary data is outlined
Casenhiser 2011 This is a two-arm RCT comprising a social-communication-based intervention for young children with autism
compared to a community treatment group (treatment as usual). Neither arm is family therapy
Chen 2006 This is a two-arm study comprising individualised hospital care for individuals with autism compared to a
family intervention. Participants were not randomised to either arm
Chou 1992 This is a two-arm study comprising a task-focused intervention, which incorporated systemic techniques,
for individuals with developmental disabilities compared with a control group receiving treatment as usual.
Participants were not randomised to either intervention
Clancy 1972 This is a description of a clinical programme of systemic and family-focused techniques for individuals with
autism. This is not a research trial and patients were not randomised to the programme
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(Continued)
Coleman 2015 This is a discussion paper about psychoeducation for family members of individuals with ASD
Coogle 2016 This is a qualitative study focusing on the experiences of family members following engagement in an early
intervention
Davis 1991 This is a two-arm RCT comprising a home-based, family-focused counselling scheme for Bangladeshi families
who had children with a range of developmental disabilities compared to treatment as usual. Neither arm is
family therapy
Drahota 2008 This is a two-arm RCT comprising a ’building confidence’ CBT intervention for young people with ASD
compared with a wait-list control. Neither arm is family therapy
Estreicher 1982 This is a single-arm study comprising family therapy techniques for families with individuals with develop-
mental disabilities. Participants were not randomised to the intervention
George 1988 This is a single-arm study comprising a therapeutic group based on systemic principles for grandparents and
extended family members of individuals with developmental delays. The intervention is not family therapy
albeit that it incorporates systemic techniques
Goll-Kopka 2009 This is a description of ’The Frankfurt Multi-family Therapy Model’ for families who have children with
developmental or global disabilities or disorders. This is a pilot study and patients were not randomised to the
programme
Heller 2015 This is a discussion paper and literature review about interventions for adults as they age. No primary data are
provided, nor is the review specifically about family therapy in ASD
Helps 2016 This is a discussion paper and narrative review about family therapy interventions for family members of
individuals with ASD
Johnson 2012 This is a review of therapeutic work with couples who have a child with ASD
Keen 2010 This is a two-arm quasi-RCT comprising a parent-focused intervention offered via home-based sessions and
a workshop for parents of children with ASD compared to a self-directed video intervention. Neither arm is
family therapy
Lordi 1964 This is a discussion paper providing an overview of infantile autism, including family-focused working
NCT01919970 This registration formpertains to a two-armRCTcomprising an exposure-basedCBT treatment, incorporating
parent input for young people with ASD, compared to treatment as usual. Neither arm is family therapy
Pickard 2017 This is a review and discussion paper about family-focused ways of working with individuals with ASD
Pillay 2010 This is a single-arm study comprising a parent-focused intervention for parents who have children with ASD.
The intervention is not family therapy
Roux 2013 This is a two-arm RCT comprising a group Stepping Stones Triple P intervention for parents of children with
a range of intellectual disabilities compared to a wait-list control. Neither arm is family therapy
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(Continued)
Shank 1991 This is a single-arm study comprising a problem-solving technique for parents of a child with a disability. The
intervention is not family therapy albeit that it incorporates systemic techniques
Siller 2013 This is a two-arm RCT comprising a focused playtime intervention for parents of children with ASD compared
with psychoeducation. Neither arm is family therapy
Smock Jordan 2016 This is a discussion paper about solution-focused therapy techniques for family members of individuals with
ASD. Case vignettes (non-RCT data) are provided
Solomon 2008 This is a two-arm RCT comprising a parent-child interaction therapy for parents of children with ASD
compared with a wait-list control. Neither arm is family therapy
Wagner 2014 This is a discussion paper, which also makes reference to a single-arm intervention about a multi-systemic
therapy for families of individuals with ASD. Participants were not randomised to the intervention
Wang 2008 This is a two-arm RCT comprising a parent training intervention for parents of children with autism compared
with a wait-list control. Neither arm is family therapy
Whittingham 2009 This is a two-arm RCT comprising the Stepping Stones Triple P positive parenting programme for parents of
children with ASD compared with a wait-list control. Neither arm is family therapy
ASD: autism spectrum disorder; CBT: cognitive behavioural therapy; RCT: randomised controlled trial.
Characteristics of studies awaiting assessment [ordered by study ID]
Spain 2017 [pers comm]
Methods From a study by Wagner 2014, we noted the following sentence: “Building on the results from our pilot work,
we obtained grant funding to conduct a small randomized clinical trial for youths with ASD and severe behavioral
problems (expected N = 30)” (p 326). We contacted the senior author in 2016 and 2017 in order to clarify the status
of the trial
Participants Not known
Interventions Not known
Outcomes Not known
Notes We corresponded with the senior author in 2016 and 2017 but insufficient detail about the study was available
ASD: autism spectrum disorder.
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
Table 1. Unused methods sections
Unused methods Description of methods
Data extraction and management The data extraction form will include subheadings relating to the following
areas
1. Study methods (including methods of randomisation, allocation
concealment, and blinding of research personnel or participants).
2. Ethical approval (provision of informed consent or assent).
3. Referral route (method through which individuals are referred or
present for family therapy).
4. Participant demographics and clinical diagnoses (including ASD and
comorbid diagnoses).
5. Instruments used to diagnose ASD (including clinician-administered
assessments with either participants or informants).
6. Active and comparator interventions (modality, content and duration
of the active and comparator interventions).
7. Outcome measurements (for individuals with ASD and their family
members; and health outcome data, if cited).
8. Results (including descriptive and inferential statistical data, as well as
study results).
9. Adverse events (e.g. whether there has been an increase in mental
health morbidities).
10. Treatment fidelity (e.g. whether a manualised treatment approach was
used, if treatment sessions were independently reviewed for adherence to
the theoretical model, and the frequency and nature of clinical supervision
for trial therapists).
We will attempt to separate the outcomes and results between sites for any
multi-centre studies. In the event that data described appear ambiguous for
any of the reports, we will contact the authors for clarification. If we are
unable to liaise with report authors, we will document this within the review,
and the review team will discuss the discrepancies
For any non-English language studies, we will endeavour to arrange for
report translation
Assessment of risk of bias in included studies DS and JS will independently assess the risk of bias of all included studies
across seven domains: random sequence generation; allocation concealment;
blinding of participants and trial staff; blinding of outcome assessments;
incomplete outcome data; selective outcome reporting; and any other po-
tential sources of bias. For each included study, we will assign each of these
domains one of three ratings: high risk of bias, low risk of bias, or unclear
risk of bias. We have detailed criteria for rating various domains of bias be-
low, with examples drawn from Chapter 8.5 of the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011a).
Random sequence generation
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Table 1. Unused methods sections (Continued)
1. High risk of bias: a non-random method is used to generate the
sequence such as allocation by alternate days or geographical location of
entry to the trial.
2. Low risk of bias: random methods (e.g. random number table or
computer random number generator) are used to generate the sequence to
produce comparable groups.
3. Unclear risk of bias: no or insufficient information is provided on the
methods used to generate the sequence to permit a judgement of high or
low risk of bias.
Allocation concealment
1. High risk of bias: participants and researchers may have been able to
foresee assignment to intervention groups due to insufficient measures
used to conceal allocation (such as open random allocation schedule,
unsealed or non-opaque envelopes).
2. Low risk of bias: adequate methods are used to conceal the allocation
(e.g. opaque envelope procedure, central allocation or by independent
personnel outside of the research team), so that participants and researchers
are unable to foresee or influence the assignment of intervention groups.
3. Unclear risk of bias: no or insufficient detail is provided on methods
used to conceal the allocation sequence to permit a judgement of high or
low risk of bias.
Blinding of participants and research personnel
1. High risk of bias: neither participants nor research personnel are
blinded to the treatment group allocation or study hypotheses, and
outcomes are likely to be influenced by such lack of blinding; or blinding
is attempted and subsequently broken; or some participants and personnel
are blinded while others are not blinded, which may introduce bias.
2. Low risk of bias: effective measures (e.g. placebo or sham therapy
sessions) are used to blind study participants and research personnel from
knowing intervention group allocation and study hypotheses; or when
blinding is not possible, study authors are able to justify that the outcome
is unlikely to be influenced by the lack of blinding.
3. Unclear risk of bias: either the study did not address this outcome or
insufficient details are provided on methods of blinding to permit a
judgement of low or high risk of bias.
Blinding of outcome assessment
1. High risk of bias: outcome assessors are not blinded to treatment
allocation of the study participants and the study hypothesis, and the
outcomes are likely to be influenced by the lack of blinding.
2. Low risk of bias: objective measures (such as biomedical measures of
cortisol levels) that are unlikely to be influenced by the lack of blinding
outcome assessors are used; participants are unaware of which intervention
they have been allocated to; or participants’ knowledge of which
intervention they are receiving does not mediate their response to
subjective outcome measures.
3. Unclear risk of bias: there is a lack of detail on methods of blinding to
permit a judgement of high or low risk of bias.
Incomplete outcome data
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Table 1. Unused methods sections (Continued)
1. High risk of bias: reasons for missing data are likely to be related to
the true outcome; missing data are not balanced across groups; or
inappropriate methods are used to impute missing data.
2. Low risk of bias: no incomplete outcome data for each main
outcome; reasons for missing data are unlikely to be related to true
outcome; missing data are balanced across groups; or appropriate methods
have been used to impute the data.
3. Unclear risk of bias: either the study did not address this outcome, or
there is insufficient detail as regards to the amount, nature, and handling of
incomplete outcome data to permit a judgement of low or high risk of bias.
Selective reporting
1. High risk of bias: not all prespecified outcomes are reported; or
outcomes are reported using methods not prespecified and for only a
subgroup of the sample; or outcomes are reported that were not
prespecified; or outcomes are reported incompletely and cannot be
included in a meta-analysis.
2. Low risk of bias: all outcomes are reported as prespecified in
published protocol, or the protocol is not available but there is convincing
text that suggests that all prespecified outcomes have been reported.
3. Unclear risk of bias: there is insufficient information (e.g. no protocol
available) to permit a judgement of high or low risk of bias.
Other sources of bias
1. High risk of bias: the study raises other important concerns, such as
bias relating to the study design or claims of fraudulence, or other sources
of bias that are not covered by the above domains.
2. Low risk of bias: there is no evidence to suggest there are any other
important concerns about bias not addressed in the domains stated above.
3. Unclear risk of bias: there may be an additional risk of bias, but there
is insufficient information to fully assess this risk, or it is unclear that the
risk would introduce bias in the study results.
We will obtain a third opinion from EP,MF or FH should there be disagree-
ment about the ’Risk of bias’ assessment or a lack of consensus about any of
the individual domains per study or in terms of the overall appraisal of the
trial. We will also attempt to contact report authors to provide clarification
about aspects of the trial, as needed
’Summary of findings’ tables We will import data from Review Manager (Review Manager 2014), into
GRADEprofiler (GRADEpro GDT), and use this software to create ’Sum-
mary of findings’ tables. These tables will provide outcome-specific informa-
tion concerning the overall quality of the body of evidence from the studies
included in the comparison, the magnitude of effect of the interventions
examined, and the sum of available data on outcomes rated as relevant to
patient care and decision making.
We will employ the GRADE approach to assess the quality of evidence
(Schünemann 2011), using the following ratings: high quality (RCTs or
quasi-RCTs with a very low risk of bias), moderate quality (RCTs or quasi-
RCTs with some evidence of risk of bias such as inadequate allocation con-
cealment), low and very low quality (RCTs or quasi-RCTs that have signifi-
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Table 1. Unused methods sections (Continued)
cant threats to internal study validity such as failure to adequately randomise
participants, lack of blinding of outcome assessors, or selective outcome re-
porting) (Schünemann 2011, Table 12.2.a).
We will include the following outcomes in the ’Summary of findings’ tables
1. Quality or quantity of social interaction or communication.
2. Mental health morbidity, including stress, anxiety, or depression.
3. Quality of life.
4. Confidence in or attributions about coping.
5. Adverse effects or events.
Measures of treatment effect Dichotomous data
For dichotomous outcomes, such as the presence or absence of challenging
behaviour(s), we will use the Mantel-Haenszel method for computing the
pooled risk ratio (RR) (Mantel 1959). We will use the RR in meta-analyses,
rather than the odds ratio (OR), because the OR can be susceptible to mis-
interpretation, which can lead to overestimation of the benefits and harms
of the intervention (Deeks 2011, Section 9.4.4.4). We will report the RR
with 95% CIs.
Continuous data
When different measures are used, we will calculate the standardised mean
difference and 95% CI. We will calculate the mean difference and 95% CI
when all outcomes are measured using the same scale in the same way
Unit of analysis issues Cluster trials
In cluster trials, the independence of individuals cannot be assumed (Higgins
2011b). As we are examining the effectiveness of an intervention for both
individuals and family members, we may identify cluster-randomised trials
If clustering has been incorporated into the analyses of primary studies, we
plan to present these data as if from a non-cluster-randomised study, but
adjust for the clustering effect.We will contact study authors for more infor-
mation if needed. If we identify cluster trials that have been analysed using
incorrect statistical methods (i.e. not taking the clustering into account), we
will contact study authors to request individual participant data so that we
may calculate an estimate of the intracluster correlation coefficient (ICC).
If we are unable to obtain this information, we will adjust sample sizes using
an estimate of the ICC from the trial or from a trial of a similar population,
with advice from a statistician, and use this to re-analyse the data. In the
event that we are unable to adjust for incorrect statistical methods used by
the cluster trials, and therefore cannot estimate the ICC with any a degree
of confidence, we will exclude the trial (Higgins 2011b).
We will investigate the robustness of our results by conducting sensitivity
analyses, for example, to explore the impact of different types of cluster-
randomisation units (such as families, health practitioners) (Higgins 2011b)
. We will also compare the results with and without cluster trials that have
not been analysed correctly by the trialists (where the ICC is estimated from
other trials for the adjustment of cluster effect) (see Sensitivity analysis)
Cross-over trials
Due to the issue of carry-over, that is, whereby the effectiveness of a second
interventionmay bemediated by the first intervention, wewill exclude cross-
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over trials
Multiple comparisons
Where a trial involves more than two treatment (or comparator) arms, we
will first assess which intervention (or comparator) groups are relevant to
our review. We will use data from the arms of the trial that are relevant to the
review objectives, but present all intervention groups in the ’Characteristics
of included studies’ tables, providing a detailed description of why we have
selected particular groups and excluded others. In the event that studies have
more than two intervention groups and a control group that are relevant to
the review, we will split the control group data proportionately to the other
two groups
Repeated measures
When a trial reports outcome data obtained atmore than one time point, we
will conduct analyses separately for each time point (e.g. postintervention
and at follow-up, if follow-up is specified by the trialist)
Dealing with missing data We will consider the possible impact of missing data on the results of the
review
Data may be missing either because (1) they have been insufficiently or
inadequately reported, or (2) due to dropout or attrition. In the event of
insufficient or inadequate reporting, we will first try to obtain any missing
data from the trial authors, including unreported data (e.g. group means
and SDs), details of dropouts, and interventions provided. We will describe
the missing data in the ’Risk of bias’ table
In either case outlined above, and when we cannot obtain data, we will
conduct analyses using ITT principles. For dichotomous outcomes (those
not deemed to be missing at random), we will impute the outcomes for the
missing participants using both the most optimistic (i.e. assuming partic-
ipants with missing data improve) and the most pessimistic (i.e. assuming
participants with missing data deteriorate) scenarios
When data are missing for continuous outcomes (e.g. data pertaining to
means or SD), we will attempt to calculate them based on the standard
errors, CIs, and t values, according to the rules described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011c). If this
information is missing, and we are unable to obtain it from trial authors, we
will report it as missing data in the review
We will also conduct a sensitivity analysis to compare the results from the
ITT analysis with the imputation and ‘available case’ analysis (see Sensitivity
analysis). If these analyses yield similar results in terms of the effects of
treatment, we will present the results of the available case analyses
Assessment of heterogeneity Within each comparison, we will first assess clinical heterogeneity (e.g. vari-
ability in active and comparator interventions, participant characteristics, or
outcome measures used) and methodological heterogeneity (e.g. variability
in study design, including differences in the nature of the randomisation
unit and the size of cluster randomised; and risk of bias, which we will assess
according to the criteria outlined in the Cochrane Handbook for Systematic
Reviews of Interventions (Deeks 2011)). If there is clinical or methodological
heterogeneity, we will extract and document all of these characteristics onto
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the data extraction form and synthesise the results narratively. We will then
assess statistical heterogeneity using the I² and Chi² statistics, and by visually
inspecting the forest plots. If we identify a substantial level of heterogeneity
in trials (e.g. the I² is more than 30% to 60%, the P value is less than 0.10 in
the Chi² test for heterogeneity, or there is a different direction of the effects)
, we will conduct prespecified subgroup analyses (see Subgroup analysis and
investigation of heterogeneity)
Assessment of reporting biases We will assess reporting biases, including (multiple) publication, selective
reporting, outcome and language biases (Sterne 2011, Table 10.1.a). First,
we will try to locate protocols of included trials. If the protocol is available,
we will compare outcomes documented in the protocol and the published
report. If the protocol is not available, we will compare outcomes listed in
the methods section of the trial report with the reported results. In addition,
we will create funnel plots to investigate the possibility of publication bias
and other small-study effects when there is a sufficient number of trials (10
or more).While funnel plots may be useful in investigating reporting biases,
there is some concern that tests for funnel plot asymmetry have limited
power to detect small-study effects, particularly when there are fewer than
10 studies, or when all studies are of a similar sample size (Sterne 2011).
In the event that funnel plots are possible, we will produce them and seek
statistical advice in their interpretation
Data synthesis We will conduct random-effects meta-analyses to produce the average effect
size of the intervention across trials. A random-effects model is considered
more appropriate than a fixed-effect model because the population and
setting of trials are likely to be different, and therefore the effects are also
likely to be different (Deeks 2011).
Subgroup analysis and assessment of heterogeneity Depending on the sample size and heterogeneity of study populations, we
propose to undertake subgroup analyses as follows:
1. children and adolescents (aged 17 years and under) versus adults
(aged 18 years and above) with ASD; and
2. individuals with ASD who have a concurrent learning disability (i.e.
IQ below 70) versus individuals with ASD and no learning disability.
To limit the risk of multiple comparisons, wewill conduct subgroup analyses
on primary outcomes only
Sensitivity analysis We will undertake sensitivity analyses to evaluate the impact of excluding
trials (or trial data) that are judged to have a high risk of bias (e.g. in terms
of the domains of random sequence generation, allocation concealment,
blinding, or outcome reporting). We will also undertake sensitivity analyses
to assess the potential impact of missing outcome data
ASD: autism spectrum disorder; CI: confidence interval; GRADE: Grades of Recommendation, Assessment, Development and Eval-
uation; ITT: intention-to-treat; IQ: intelligence quotient; RCTs: randomised controlled trials; SD: standard deviation.
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A P P E N D I C E S
Appendix 1. Search strategies
Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library
#1[mh “child development disorders, pervasive”]
#2[mh ˆ“Developmental Disabilities”]
#3pervasive development* disorder*
#4(pervasive near/3 child*)
#5(PDD or PDDs or PDD-NOS or ASD or ASDs)
#6autis*
#7asperger*
#8kanner*
#9childhood near/1 schizophreni*
#10{or #1-#9}
#11[mh “family therapy”]
#12[mh “group therapy”]
#13[mh “psychotherapy, group”]
#14[mh “couples therapy”]
#15[mh “marital therapy”]
#16(systemic* near/3 psychotherap*)
#17(systemic* near/3 psycho-therap*)
#18(systemic* near/3 famil*)
#19(famil* near/3 (intervention* or therap* or treat* or program*)) 4
#20(famil* near/3 (psychotherap* or psychoeducation* or psycho next education* or psycho next therap*)) 3
#21((marriage or marital or couple*) near/3 therap*)
#22(famil* near/1 (involv* or integrat* or participat* or focus*))
#23(psychodynamic or psycho next dynamic)
#24(group* near/3 psychotherap*)
#25(group* near/3 psycho next therap*)
#26(systemic next therap*)
#27(solution next focus*)
#28(narrative near/3 therap*)
#29{or #11-#28}
#30#10 and #29 in Trials
MEDLINE Ovid
1 exp child development disorders, pervasive/
2 Developmental Disabilities/
3 pervasive development$ disorder$.tw.
4 (pervasive adj3 child$).tw.
5 (PDD or PDDs or PDD-NOS or ASD or ASDs).tw.
6 autis$.tw.
7 asperger$.tw.
8 kanner$.tw.
9 childhood schizophreni$.tw.
10 or/1-9
11 family therapy/
12 group therapy/
13 psychotherapy, group/
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14 couples therapy/
15 marital therapy/
16 (systemic$ adj3 psychotherap$).tw.
17 (systemic$ adj3 psycho-therap$).tw.
18 (systemic$ adj3 famil$).tw.
19 (famil$ adj3 (intervention$ or therap$ or treat$ or program$)).tw.
20 (famil$ adj3 (psychotherap$ or psychoeducation$ or psycho-education$ or psycho-therap$)).tw.
21 ((marriage or marital or couple$) adj3 therap$).tw.
22 (famil$ adj1 (involv$ or integrat$ or participat$ or focus$)).tw.
23 (psychodynamic or psycho-dynamic).tw.
24 (group$ adj3 psychotherap$).tw.
25 (group$ adj3 psycho-therap$).tw.
26 systemic therap$.tw.
27 solution focus$.tw.
28 (narrative adj1 therap$).tw.
29 or/11-28
30 10 and 29
MEDLINE Ovid Epub Ahead of Print
1 pervasive development$ disorder$.tw.
2 (pervasive adj3 child$).tw.
3 (PDD or PDDs or PDD-NOS or ASD or ASDs).tw.
4 autis$.tw.
5 asperger$.tw.
6 kanner$.tw.
7 childhood schizophrenia.tw.
8 or/1-7
9 (systemic$ adj3 psychotherap$).tw.
10 (systemic$ adj3 psycho-therap$).tw.
11 (systemic$ adj3 famil$).tw.
12 (famil$ adj3 (intervention$ or therap$ or treat$ or program$)).tw.
13 (famil$ adj3 (psychotherap$ or psychoeducation$ or psycho-education$ or psycho-therap$)).tw.
14 (famil$ adj1 (involv$ or integrat$ or participat$ or focus$)).tw.
15 ((marriage or marital or couple$) adj3 therap$).tw.
16 (psychodynamic or psycho-dynamic).tw.
17 (group$ adj3 psychotherap$).tw.
18 (group$ adj3 psycho therap$).tw.
19 systemic therap$.tw.
20 solution focus$.tw.
21 (narrative adj1 therap$).tw.
22 or/9-21
23 8 and 22
MEDLINE Ovid In-Process and Other Non-Indexed Citations
1 pervasive development$ disorder$.tw.
2 (pervasive adj3 child$).tw.
3 (PDD or PDDs or PDD-NOS or ASD or ASDs).tw.
4 autis$.tw.
5 asperger$.tw.
6 kanner$.tw.
7 childhood schizophrenia.tw.
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8 or/1-7
9 (systemic$ adj3 psychotherap$).tw.
10 (systemic$ adj3 psycho-therap$).tw.
11 (systemic$ adj3 famil$).tw.
12 (famil$ adj3 (intervention$ or therap$ or treat$ or program$)).tw.
13 (famil$ adj3 (psychotherap$ or psychoeducation$ or psycho-education$ or psycho-therap$)).tw.
14 (famil$ adj1 (involv$ or integrat$ or participat$ or focus$)).tw.
15 ((marriage or marital or couple$) adj3 therap$).tw.
16 (psychodynamic or psycho-dynamic).tw.
17 (group$ adj3 psychotherap$).tw.
18 (group$ adj3 psycho therap$).tw.
19 systemic therap$.tw.
20 solution focus$.tw.
21 (narrative adj1 therap$).tw.
22 or/9-21
23 8 and 22
Embase OVID
1 exp autism/
2 pervasive development$ disorder$.tw.
3 (PDD or PDDs or ASD or ASDs).tw.
4 autis$.tw.
5 asperger$.tw.
6 kanner$.tw.
7 childhood schizophreni$.tw.
8 Rett$.tw.
9 (pervasive adj3 child$).tw.
10 or/1-9
11 family therapy/
12 group therapy/
13 marital therapy/
14 (systemic$ adj3 psychotherap$).tw.
15 (systemic$ adj3 psycho-therap$).tw.
16 (systemic$ adj3 famil$).tw.
17 (famil$ adj3 (intervention$ or therap$ or treat$ or program$)).tw.
18 (famil$ adj3 (psychotherap$ or psychoeducation$ or psycho-education$ or psycho-therap$)).tw.
19 ((marriage or marital or couple$) adj3 therap$).tw.
20 (famil$ adj1 (involv$ or integrat$ or participat$ or focus$)).tw.
21 (psychodynamic or psycho-dynamic).tw.
22 (group$ adj3 psychotherap$).tw.
23 (group$ adj3 psycho-therap$).tw.
24 systemic therap$.tw.
25 solution focus$.tw.
26 (narrative adj1 therap$).tw.
27 or/11-26
28 10 and 27
CINAHLPlus EBSCOhost (Cumulative Index to Nursing and Allied Health Literature)
S27 S9 AND S26
S26 S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24
OR S25
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S25 (narrative N1 therap*)
S24 solution focus*
S23 systemic therap*
S22 (group* N3 (psychotherap* or psycho-therap*) )
S21 (psychodynamic or psycho-dynamic)
S20 (famil* N1 (involv* or integrat* or participat* or focus*))
S19 ((marriage or marital or couple*) N3 therap*)
S18 (famil* N3 (psychotherap* or psychoeducation* or psycho-education*or psycho-therap*))
S17 (famil* N3 (intervention* or therap* or treat* or program*))
S16 (systemic* N3 famil*)
S15 (systemic* N3 psycho-therap*)
S14 (systemic* N3 psychotherap*)
S13 (MH “Couples Counseling”)
S12 (MH “Psychotherapy, Group”)
S11 (MH “Family Therapy”)
S10 (MH “Family Systems Theory”) OR (MH “Family Services”)
S9 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8
S8 (MH “Developmental Disabilities”)
S7 childhood schizophren*
S6 Kanner*
S5 Rett*
S4 Asperger*
S3 (autis* or ASD or ASDs)
S2 (pervasive development* disorder* or PDD or PDDs)
S1 (MH “Child Development Disorders, Pervasive+”)
Cochrane Database of Systematic Reviews (CDSR) part of the Cochrane Library
#1[mh “child development disorders, pervasive”]
#2[mh ˆ“Developmental Disabilities”]
#3“pervasive development* disorder*”:ti,ab
#4(pervasive near/3 child*):ti,ab
#5autis* :ti,ab
#6asperger*:ti,ab
#7kanner*:ti,ab
#8{or #1-#7}
#9[mh “family therapy”]
#10[mh “group therapy”]
#11[mh “psychotherapy, group”]
#12[mh “couples therapy”]
#13[mh “marital therapy”]
#14(systemic* near/3 psychotherap*):ti,ab
#15(systemic* near/3 psycho-therap*):ti,ab
#16(systemic* near/3 famil*):ti,ab
#17(famil* near/3 (intervention* or therap* or treat* or program*)):ti,ab
#18(famil* near/3 (psychotherap* or psychoeducation* or psycho next education* or psycho next therap*)):ti,ab
#19((marriage or marital or couple*) near/3 therap*):ti,ab
#20(famil* near/1 (involv* or integrat* or participat* or focus*)):ti,ab
#21(psychodynamic or psycho next dynamic):ti,ab
#22(group* near/3 psychotherap*):ti,ab
#23(group* near/3 psycho next therap*):ti,ab
#24(“systemic therap*”):ti,ab
#25(“solution focus*”):ti,ab
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#26(narrative near/1 therap*):ti,ab
#27{or #9-#26}
#28#8 and #27
Database of Abstracts of Reviews of Effects (DARE) part of the Cochrane Library
#1[mh “child development disorders, pervasive”]
#2[mh ˆ“Developmental Disabilities”]
#3“pervasive development* disorder*”
#4(pervasive near/3 child*)
#5autism or autistic
#6asperger*
#7kanner*:
#8{or #1-#7}
#9[mh “family therapy”]
#10[mh “group therapy”]
#11[mh “psychotherapy, group”]
#12[mh “couples therapy”]
#13[mh “marital therapy”]
#14(systemic* near/3 psychotherap*)
#15(systemic* near/3 psycho-therap*)
#16(systemic* near/3 famil*):
#17(famil* near/3 (intervention* or therap* or treat* or program*))
#18(famil* near/3 (psychotherap* or psychoeducation* or psycho next education* or psycho next therap*))
#19((marriage or marital or couple*) near/3 therap*)
#20(famil* near/1 (involv* or integrat* or participat* or focus*))
#21(psychodynamic or psycho next dynamic)
#22(group* near/3 psychotherap*)
#23(group* near/3 psycho next therap*)
#24(“systemic therap*”)
#25(“solution focus*”):
#26(narrative near/1 therap*)
#27{or #9-#26}
#28#8 and #27
ERIC EBSCOhost (Education Resources Information Center)
S27 S9 AND S26
S26 S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24
OR S25
S25 (narrative N1 therap*)
S24 “solution focus*”
S23 “systemic therap*”
S22 (group* N3 (psychotherap* or psycho-therap*))
S21 (psychodynamic or psycho-dynamic)
S20 TI(famil* N1 (involv* or integrat* or participat* or focus*)) OR AB(famil* N1 (involv* or integrat* or participat* or focus*)
S19 TI ((marriage or marital or couple*) N3 therap*) OR AB((marriage or marital or couple*) N3 therap*) Search modes - Boolean/
Phrase
S18 TI(famil* N3 (psychotherap* or psychoeducation* or psycho-education* or psycho-therap*))OR AB(famil* N3 (psychotherap* or
psychoeducation* or psycho-education* or psycho-therap*))
S17 TI(famil* N3 (intervention* or therap* or treat* or program*)) ORAB(famil* N3 (intervention* or therap* or treat* or program*))
S16 (systemic* N3 famil*)
S15 (systemic* N3 psycho-therap*)
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S14 (systemic* N3 psycho-therap*)
S13 (systemic* N3 psychotherap*)
S12 DE “Marriage Counseling”
S11 DE “Group Counseling” OR DE “Group Therapy”
S10 DE “Family Counseling” OR DE “Family Involvement” OR DE “Family Programs”
S9 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8
S8 childhood schizophren*
S7 Kanner*
S6 Rett*
S5 Asperger*
S4 (autis* or ASD or ASDs)
S3 (pervasive development* disorder* or PDD or PDDs)
S2 DE “Pervasive Developmental Disorders” OR DE “Asperger Syndrome” OR DE “Autism”
S1 DE “Developmental Disabilities”
PsycINFO (Ovid)
1 exp pervasive developmental disorders/
2 Developmental disabilities/
3 pervasive development$ disorder$.tw.
4 (pervasive adj3 child$).tw.
5 autis$.tw.
6 asperger$.tw.
7 (autis$ or ASD or ASDs).tw.
8 Rett$.tw.
9 Kanner$.tw.
10 (PDD or PDDs or PDD-NOS).tw.
11 childhood schizophreni$.tw.
12 or/1-11
13 exp family therapy/
14 family intervention/
15 group psychotherapy/
16 conjoint therapy/
17 couples therapy/
18 marriage counseling/
19 (systemic$ adj3 psychotherap$).tw.
20 (systemic$ adj3 psycho-therap$).tw.
21 (systemic$ adj3 famil$).tw.
22 (famil$ adj3 (intervention$ or therap$ or treat$ or program$)).tw.
23 (famil$ adj3 (psychotherap$ or psychoeducation$ or psycho-education$ or psycho-therap$)).tw.
24 ((marriage or marital or couple$) adj3 therap$).tw.
25 (famil$ adj1 (involv$ or integrat$ or participat$ or focus$)).tw.
26 (psychodynamic or psycho-dynamic).tw.
27 (group$ adj3 psychotherap$).tw.
28 (group$ adj3 psycho-therap$).tw.
29 systemic therap$.tw.
30 solution focus$.tw.
31 (narrative adj1 therap$).tw.
32 or/13-31
33 12 and 32
Sociological Abstracts ProQuest
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SU.EXACT(“Autism”) OR autis* or asperger* or kanner* or Rett* or pervasive N3 disorder* or pervasive N3 child* OR PDD or PDDs
or PDD-NOS or ASD or ASDs) AND ((famil* N/3 (intervention* or therap* or treat* or program*)) or (famil* N/3 (psychotherap* or
psychoeducation* or “psycho education*” or “psycho therap*”)) or (systemic* N/3 psychotherap*) or (systemic* N/3 “psycho- therap*”)
or (famil* N/1 (involv* or integrat* or participat* or focus*)) OR (group* N/3 psychotherap*) or systemic therap* or (group* N/3
psychotherap*) or (group* N/3 (“psycho-therap*” or psychoeducation* or “psycho education*” or “psycho therap*”)))
Dissertation Abstracts International ProQuest
(ab(child developmental disorders) OR ab((pervasive developmental disorders OR developmental disabilit$)) OR ab((pervasive de-
velopment$ disorder$ OR pervasive adj3 child$)) OR ab((PDD OR PDDs OR PDD-NOS OR ASD OR ASDs OR autis$)) OR
ab((asperger$ OR kanner$)) OR ab(childhood schizophrenia)) AND (ab(family therapy)OR ab((group therapy OR group psychother-
apy)) OR ab((couples therapy OR marital therapy)) OR ab((systemic$ adj3 psychotherap$ OR systemic$ adj3 psycho-therap$))
OR ab((systemic$ adj3 famil$ OR famil$ adj3 (intervention$ OR therap$ OR treat$ OR program$))) OR ab((famil$ adj3 (psy-
chotherap$ OR psychoeducation$ OR psycho-education$ OR psycho-therap$) OR (marriage ORmarital OR couple$) adj3 therap$))
OR ab((famil$ adj1 (involv$ OR integrat$ OR participat$ OR focus$) OR psychodynamic OR psycho-dynamic)) OR ab((group$
adj3 psychotherap$ OR group$ adj3 psycho therap$)) OR ab((systemic therap$ OR solution focus$)) OR ab(narrative adj1 therap))
AutismData
(autism.org.uk/autismdata)
Searched “family therapy” as keyword
Records were compared manually with EN library; 6 unique records added to Endnote
UK Clinical Research Network (UKCRN) Study Portfolio
(public.ukcrn.org.uk/search)
Searches:
Speciality : Mental health
Subtopic: Autism spectrum disoders
Research summary: family
Speciality : Mental health
Subtopic: Autism spectrum disoders
Research summary: systemic
Speciality : Mental health
Subtopic: Autism spectrum disoders
Research summary: psychotherapy
Speciality : Mental health
Subtopic: Autism spectrum disoders
Research summary: multisystemic
UK Clinical Trials Gateway (UKCTG)
(ukctg.nihr.ac.uk)
family therapy autis*
systemic autis*
multisystemic autis*
ClinicalTrials.gov
(clinicaltrials.gov/ct2/home)
autism | (family OR systemic OR group) AND (therapy) OR autism | (family OR systemic OR group) AND (psychotherapy)
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World Health Organisation International Clinical Trials Registry Platform (WHO ICTRP)
(apps.who.int/trialsearch/AdvSearch.aspx)
Basic search: Autism AND group OR autism AND family or autism AND parent OR autism AND systemic
Appendix 2. Record of searches
Database Search
date
Date
range/issue
Number of
records
Cochrane Central Register of
Controlled Trials (CENTRAL)
in the Cochrane Library
23 October 2015 Issue 9 of 12, September 2015 75
18 January 2017 Issue 11 of 12, November 2016 15
MEDLINE Ovid 22 October 2015 1946 to October Week 3 2015 559
17 January 2017 1946 to December Week 1 2016 74
MEDLINE Ovid Epub Ahead
of Print
17 January 2017 16 January 2017 15
MEDLINE Ovid In-Process &
Other Non-Indexed Citations
17 January 2017 16 January 2017 39
Embase OVID 22 October 2015 1974 to 2015 Week 42 695
17 January 2017 1974 to 2017 Week 3 94
CINAHL Plus EBSCOhost
(Cumulative Index to Nursing
and Allied Health Literature)
23 October 2015 1937 to current 402
17 January 2017 1937 to current 22
Cochrane Database of System-
atic Reviews (CDSR) part of the
Cochrane Library
23 October 2015 Issue 10 of 12, October 2015 15
18 January 2017 Issue 1 of 12, January 2015 6
Database of Abstracts of Re-
views of Effects (DARE) part of
the Cochrane Library
23 October 2015 Issue 2 of 4, April 2015 4
ERIC EBSCOhost (Education
Resources Information Center)
23 October 2015 1966 to current 564
17 January 2017 1966 to current 32
PsycINFO OVID 22 October 2015 1967 to October Week 3 2015 1417
17 January 2017 1967 to January Week 2 2017 118
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(Continued)
Sociological Abstracts
ProQuest
23 October 2015 1952 to current 52
18 January 2017 1952 to current 4
Dissertation Abstracts Interna-
tional ProQuest
4 November 2015 1743 to current 176
16 January 2017 1743 to current 215
AutismData (autism.org.uk/
autismdata)
23 October 2015 All years 6
18 January 2017 All years 4
UK Clinical Research Network
Study Portfolio (UKCRN;
public.ukcrn.org.uk/search)
; replaced by UK Clinical Trials
Gateway
23 October 2015 All years 1
UK Clinical Trials Gateway
(UKCTG; ukctg.nihr.ac.uk)
; replaces UK Clinical Research
Network Study Portfolio
18 January 2017 All years 1
ClinicalTrials.gov (
clinicaltrials.gov/ct2/home)
23 October 2015 All years 82
18 January 2017 All years 24
World Health Organisation In-
ternational Clinical Trials Reg-
istry Platform (WHO IC-
TRP; apps.who.int/trialsearch/
AdvSearch.aspx)
23 October 2015 All years 91
18 January 2017 All years 3
Total records 4805
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We did not produce a ’Summary of findings’ table(s), as planned, as no studies were included in this review.
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